| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6126192 | Travel Medicine and Infectious Disease | 2015 | 5 Pages |
Abstract
Clinical failure of Malarone⢠chemoprophylaxis is extremely rare. We report a case of Plasmodium falciparum malaria in a returned traveler to Ghana who fully adhered to atovaquone-proguanil (Malaroneâ¢) chemoprophylaxis daily dosing, yet took the pills on an empty stomach. Screening of the P. falciparum isolate revealed triple codon mutation of Dhfr at positions 51, 59, and 108. Plasma drug levels of both atovaquone and proguanil revealed sub-therapeutic concentrations.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Andrea K. Boggild, Rachel Lau, Denis Reynaud, Kevin C. Kain, Marvin Gerson,